Last reviewed · How we verify

Scalp block with 0.5% plain Marcaine — Competitive Intelligence Brief

Scalp block with 0.5% plain Marcaine (Scalp block with 0.5% plain Marcaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Scalp block with 0.5% plain Marcaine (Scalp block with 0.5% plain Marcaine) — Chiang Mai University. Bupivacaine blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce local anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Scalp block with 0.5% plain Marcaine TARGET Scalp block with 0.5% plain Marcaine Chiang Mai University marketed Local anesthetic (amide) Voltage-gated sodium channels
Ropivacaine concentration low Ropivacaine concentration low Oslo University Hospital marketed Local anesthetic Voltage-gated sodium channels
Levobupivacaine continuous infusion Levobupivacaine continuous infusion Fondazione IRCCS Policlinico San Matteo di Pavia marketed Local anesthetic (amide) Voltage-gated sodium channels
Extended Phenytoin Sodium Extended Phenytoin Sodium Bristol-Myers Squibb marketed Aromatic antiepileptic drug (hydantoin) Voltage-gated sodium channels
Levobupivacaine lidocaine spinal anesthesia Levobupivacaine lidocaine spinal anesthesia Diskapi Teaching and Research Hospital marketed Local anesthetic Voltage-gated sodium channels
Nerve block with Lidocain Nerve block with Lidocain Tehran University of Medical Sciences marketed Local anesthetic Voltage-gated sodium channels
Bupivacaine Hcl 0.75% Inj Bupivacaine Hcl 0.75% Inj Rothman Institute Orthopaedics marketed Local anesthetic Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

  1. Poznan University of Medical Sciences · 4 drugs in this class
  2. Nantes University Hospital · 3 drugs in this class
  3. Bozyaka Training and Research Hospital · 2 drugs in this class
  4. ASST Gaetano Pini-CTO · 2 drugs in this class
  5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
  6. Chiang Mai University · 1 drug in this class
  7. Beijing Tiantan Hospital · 1 drug in this class
  8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
  10. China Medical University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Scalp block with 0.5% plain Marcaine — Competitive Intelligence Brief. https://druglandscape.com/ci/scalp-block-with-0-5-plain-marcaine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: